TY  - GEN
AU  - Ribas,Antoni
AU  - Kefford,Richard
AU  - Marshall,Margaret A
AU  - Punt,Cornelis J A
AU  - Haanen,John B
AU  - Marmol,Maribel
AU  - Garbe,Claus
AU  - Gogas,Helen
AU  - Schachter,Jacob
AU  - Linette,Gerald
AU  - Lorigan,Paul
AU  - Kendra,Kari L
AU  - Maio,Michele
AU  - Trefzer,Uwe
AU  - Smylie,Michael
AU  - McArthur,Grant A
AU  - Dreno,Brigitte
AU  - Nathan,Paul D
AU  - Mackiewicz,Jacek
AU  - Kirkwood,John M
AU  - Gomez-Navarro,Jesus
AU  - Huang,Bo
AU  - Pavlov,Dmitri
AU  - Hauschild,Axel
TI  - Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma
SN  - 1527-7755
PY  - 2013///0329
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Colitis
KW  - chemically induced
KW  - Diarrhea
KW  - Drug Administration Schedule
KW  - Drug Eruptions
KW  - etiology
KW  - Fatigue
KW  - Female
KW  - Humans
KW  - Ipilimumab
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Nausea
KW  - Pruritus
KW  - Salvage Therapy
KW  - methods
KW  - Skin Neoplasms
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2012.44.6112
ER  -